958 related articles for article (PubMed ID: 19460674)
1. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
2. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass.
Chikunguwo SM; Wolfe LG; Dodson P; Meador JG; Baugh N; Clore JN; Kellum JM; Maher JW
Surg Obes Relat Dis; 2010; 6(3):254-9. PubMed ID: 20303324
[TBL] [Abstract][Full Text] [Related]
3. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up.
DiGiorgi M; Rosen DJ; Choi JJ; Milone L; Schrope B; Olivero-Rivera L; Restuccia N; Yuen S; Fisk M; Inabnet WB; Bessler M
Surg Obes Relat Dis; 2010; 6(3):249-53. PubMed ID: 20510288
[TBL] [Abstract][Full Text] [Related]
4. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
[TBL] [Abstract][Full Text] [Related]
5. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
[TBL] [Abstract][Full Text] [Related]
6. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.
Hamza N; Abbas MH; Darwish A; Shafeek Z; New J; Ammori BJ
Surg Obes Relat Dis; 2011; 7(6):691-6. PubMed ID: 20688578
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Viaplana J; Corcelles R; Lacy A; Vidal J
Ann Surg; 2012 Dec; 256(6):1023-9. PubMed ID: 22968072
[TBL] [Abstract][Full Text] [Related]
8. Weight loss outcome of revisional bariatric operations varies according to the primary procedure.
Brolin RE; Cody RP
Ann Surg; 2008 Aug; 248(2):227-32. PubMed ID: 18650632
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study.
Chouillard EK; Karaa A; Elkhoury M; Greco VJ;
Surg Obes Relat Dis; 2011; 7(4):500-5. PubMed ID: 21459682
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y divided gastric bypass results in the same weight loss as duodenal switch for morbid obesity.
Deveney CW; MacCabee D; Marlink K; Welker K; Davis J; McConnell DB
Am J Surg; 2004 May; 187(5):655-9. PubMed ID: 15135686
[TBL] [Abstract][Full Text] [Related]
11. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
12. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Spector D; Shikora S
Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
[TBL] [Abstract][Full Text] [Related]
13. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
[TBL] [Abstract][Full Text] [Related]
14. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.
Pinheiro JS; Schiavon CA; Pereira PB; Correa JL; Noujaim P; Cohen R
Surg Obes Relat Dis; 2008; 4(4):521-5; discussion 526-7. PubMed ID: 18539540
[TBL] [Abstract][Full Text] [Related]
15. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.
Bayham BE; Greenway FL; Bellanger DE; O'Neil CE
Diabetes Technol Ther; 2012 Jan; 14(1):30-4. PubMed ID: 21933001
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity: experience with 50 patients.
Khalaileh A; Matot I; Schweiger C; Appelbaum L; Elazary R; Keidar A
Isr Med Assoc J; 2008 May; 10(5):350-3. PubMed ID: 18605357
[TBL] [Abstract][Full Text] [Related]
17. Outcomes among elderly bariatric patients at a high-volume center.
Dunkle-Blatter SE; St Jean MR; Whitehead C; Strodel W; Bennotti PN; Still C; Reed MJ; Wood CG; Petrick AT
Surg Obes Relat Dis; 2007; 3(2):163-9; discussion 169-70. PubMed ID: 17331804
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.
Zervos EE; Agle SC; Warren AJ; Lang CG; Fitzgerald TL; Dar M; Rotondo MF; Pories WJ
J Am Coll Surg; 2010 May; 210(5):564-72, 572-4. PubMed ID: 20421005
[TBL] [Abstract][Full Text] [Related]
19. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.
Agrawal V; Krause KR; Chengelis DL; Zalesin KC; Rocher LL; McCullough PA
Surg Obes Relat Dis; 2009; 5(1):20-6. PubMed ID: 18951068
[TBL] [Abstract][Full Text] [Related]
20. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
